Imaging: MRI improves cost and accuracy of prostate cancer biopsy
Randomized trials of screening for localized prostate cancer on the basis of crude PSA thresholds and 6-12-core template biopsies had disappointing results. To improve patient outcomes, novel diagnostic tools with a high discriminative ability for clinically significant cancer are needed. The use of MRI can improve detection at biopsy without disproportionate increases in costs.
|ISBN||1759-4820 (Electronic) 1759-4812 (Linking)|
|Authors||Thompson, J.; Stricker, P.|
|Publisher Name||Nature Reviews Urology|
|URL link to publisher's version||https://www.ncbi.nlm.nih.gov/pubmed/29116256|